tetrandrine has been researched along with Carcinoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, L; Daqing, L; Li, J; Wang, J; Wang, K; Wu, X; Zhang, G; Zhuang, S | 1 |
| Chang, SH; Cho, HS; Cho, MH; Chung, YS; Hanifah, H; Hwang, SK; Jin, H; Kwon, JT; Lee, ES; Noh, MS; Park, SJ; Shin, JY; Tehrani, AM; Woo, M; Xu, CX | 1 |
2 other study(ies) available for tetrandrine and Carcinoma
| Article | Year |
|---|---|
[Effects of tetrandrine on enhancing radiosensitivity of human nasopharyngeal carcinoma cells].
Topics: Apoptosis; Benzylisoquinolines; Carcinoma; Cell Line, Tumor; DNA Repair; Humans; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Metastasis; Radiation Tolerance | 2014 |
Synergistic effect of ERK inhibition on tetrandrine-induced apoptosis in A549 human lung carcinoma cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Benzylisoquinolines; Carcinoma; Cell Line, Tumor; Dose-Response Relationship, Drug; Extracellular Signal-Regulated MAP Kinases; Humans; Lung Neoplasms | 2009 |